ATR inhibitor AZD6738 enhances the antitumor activity of radiotherapy and immune checkpoint inhibitors by potentiating the tumor immune microenvironment in hepatocellular carcinoma

BACKGROUND: Radioimmunotherapy has a promising antitumor effect in hepatocellular carcinoma (HCC), depending on the regulatory effect of radiotherapy on tumor immune microenvironment. Ionizing radiation (IR)-induced DNA damage repair (DDR) pathway activation leads to the inhibition of immune microen...

Descripción completa

Detalles Bibliográficos
Autores principales: Sheng, Hailong, Huang, Yan, Xiao, Yazhi, Zhu, Zhenru, Shen, Mengying, Zhou, Peitao, Guo, Zeqin, Wang, Jian, Wang, Hui, Dai, Wencong, Zhang, Wanjun, Sun, Jingyuan, Cao, Chuanhui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Clinical/Translational Cancer Immunotherapy
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7254123/
https://www.ncbi.nlm.nih.gov/pubmed/32461345
http://dx.doi.org/10.1136/jitc-2019-000340

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7254123/
https://www.ncbi.nlm.nih.gov/pubmed/32461345
http://dx.doi.org/10.1136/jitc-2019-000340

Ejemplares similares